• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent
 

Cognition Model

We have the capabilities to conduct preclinical studies around the cognition model

What is the Cognition Model?

A cognitive model is an estimation of animal cognitive processes for the purposes of comprehension and prediction of factors.

Transpharmation has a vast understanding in preclinical cognition research obtained through decades of experience running disease area portfolios for Parkinson’s disease, Alzheimer’s disease and Schizophrenia within GlaxoSmithKline. Most importantly, our highly skilled technical staff appreciate the subtleties involved in evaluating rodent cognitive processes, ensuring all our assays are highly robust and reproducible, ensuring a respectable study is carried out.

We focus on delivering carefully selected cognition models which are disease-relevant thereby offering the option to evaluate NCEs against pharmacologically induced cognition impairments, (e.g scopolamine) or natural impairments, (age, test parametric manipulation) across multiple disease areas.

Cognition models we offer:

  • Novel object recognition
  • temporal deficit
  • pharmacological deficit, (scopolamine, sub-chronic PCP)
  • Delayed-non-match to position
  • Reversal learning
  • Attentional set shifting

cognition modelTo discuss your requirements further and get your project underway please do not hesitate to speak with us. We are always developing new areas of discovery within our preclinical field of expertise. If there is something particular that is not listed here please do contact us.

Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk


Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design